News

Emmanuelle Passegué: Making Better Blood

Emmanuelle Passegué’s passion for blood is focused on rejuvenation and longer life. This may sound like something out of a vampire story, but her work is rooted in a different kind of mystery: one that could hold the key to how well we age and respond to diseases. “I love the mystery,” she says of

Tool Boosts Accuracy in Assessing Breast Cancer Risk

A national risk model that gauges a woman’s chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent increase in a subset of women whose five-year risk is estimated at 3

Common Class of 'Channel Blocking' Drugs May Find a Role in Cancer Therapy

Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of

California Initiative to Advance Precision Medicine Announces Funding for 2 Projects

Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr. The initiative is being hosted by UC San Francisco, in conjunction with UC

UCSF Leaders Present Capital Strategy to UC Regents

UC San Francisco Chancellor Sam Hawgood, MBBS, last week presented a plan to a UC Regents committee to invest in four projects that are critical to achieving the University’s overall capital strategy to strengthen its research, education and patient care programs and to support the work of its

Minority Training Program Aims to Eliminate Cancer Disparities

Over the last decade, better treatment and prevention efforts have helped reduce the incidence of cancer by 0.9 percent each year – yet the rate of progress hasn’t been the same for certain racial and ethnic minorities. Luis Rodriguez (center) participates in a group activity at the Minority

For Prostate Cancer Patients, Risk-Specific Therapies Now More the Norm

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco. In the first study to document updated treatment